Hepatic Jagged1 expression studies

Hepatology

Volumn 30, Issue 5, 1999, Pages 1269-1275

  Louis, Anthonise A ^a   Van Eyken, Peter ^b   Haber, Barbara A ^a   Hicks, Carol ^c   Weinmaster, Gerry ^c   Taub, Rebecca ^a   Rand, Elizabeth B ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE RECEPTOR;

ADOLESCENT; ALAGILLE SYNDROME; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL MATURATION; FETUS; FETUS LIVER; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGING; ANIMALS; CALCIUM-BINDING PROTEINS; CHILD; EMBRYONIC AND FETAL DEVELOPMENT; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GESTATIONAL AGE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; LIVER DISEASES; MEMBRANE PROTEINS; PROTEINS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032737819     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300512     Document Type: Article

References (17)

1. Li L, Krantz ID, Deng Y, Genin A, Banta AB, Collins CC, Qi M, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notchl. Nat Genet 1997;16:243-251.
2. Oda T, Elkahloun AG, Pike BL, Okajima K, Krantz ID, Genin A, Piccoli DA, et al. Mutations in the human Jaggedl gene are responsible for Alagille syndrome. Nat Genet 1997;16:235-242.
3. Krantz ID, Colliton RP, Genin A, Rand EB, Li L, Piccoli DA, Spinner NB. Spectrum and frequency of Jagged1 mutations in Alagille syndrome patients and their families. Am J Hum Genet 1998;62:1361-1369.
4. Alagille D, Estrada A, Hadchouel M, Gautier M, Odievre M, Dommergues JP. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases. J Pediatr 1987;110:195-200.
5. Mueller RFM. The Alagille syndrome (arteriohepatic dysplasia). J Med Genet 1987;24:621-626.
6. Krantz ID, Piccoli DA, Spinner NB. Alagille syndrome (syndrome of the month). J Med Genet 1997;34:152-157.
7. Emerick KM, Rand EB, Goldmuntz E, Krantz ID, Spinner NB, Piccoli DA. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. HEPATOLOGY 1999;29:822-829.
8. Kahn E. Paucity of interlobular bile ducts, Arteriohepatic dysplasia and nonsyndromic bile duct paucity. Perspect Pediatr Pathol 1991;14:168-215.
9. Hasida Y, Yunis EJ. Syndromic paucity of the interlobular bile ducts: hepatic histopathology of the early and endstage liver. Pediatr Pathol 1988;8:1-15.
10. Hadchouel M. Paucity of interlobular bile ducts. Semin Diagn Pathol 1992;9:24-30.
11. Artavanis-Tsakonas S, Matsuno K, Fortini M. Notch signaling. Science 1995;268:225-232.
12. Weinmaster G. The ins and outs of Notch signaling. Mol Cell Neurosci 1997;9:91-102.
13. Gridley T. Notch signaling in vertebrate development and disease. Mol Cell Neurosci 1997;9:103-108.
14. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: cell fate control and signal integration in development. Science 1999;284:770-776.
15. Xue Y, Gao X, Lindsell CE, Norton CR, Chang B, Hicks C, Gendron-Maguire M, et al. Embryonic lethality and vascular defects in mice lacking the Notch ligand Jagged1. Hum Mol Genet 1999;8:723-730.
16. Desmet VJ. Congenital diseases of intrahepatic bile ducts: variations on the theme "ductal plate malformation." HEPATOLOGY 1992;16:1069-1083.
17. Zimrin AB, Pepper MS, McMahon GA, Nguyen F, Montesano R, Maciag T. An antisense oligonucleotide to the Notch ligand Jagged enhances fibroblast growth factor-induced angiogenesis in vitro. J Biol Chem 1996;271:32499-32502.